4.6 Review

Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Review Oncology

A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines

Sang Soo Eom et al.

Summary: Countries have diverse treatment guidelines for gastric cancer based on their expertise and research results. This review compared treatment guidelines from five countries and found differences in endoscopic treatment, surgery, perioperative period, and systemic treatment.

JOURNAL OF GASTRIC CANCER (2022)

Article Oncology

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

S. H. Park et al.

Summary: The study compared three adjuvant treatment regimens for gastric cancer patients and found that adjuvant SOX or SOXRT was effective in prolonging disease-free survival (DFS) compared to S-1 monotherapy. However, there was no significant difference in DFS between SOX and SOXRT, and adverse events were manageable in each treatment arm.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study

Sung E. Oh et al.

Summary: This study compared the long-term efficacy of TS-1 and XELOX adjuvant chemotherapy in gastric cancer patients, showing similar outcomes in advanced stages but potential benefits of the XELOX regimen for stage II patients.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)

Review Oncology

Current status of adjuvant chemotherapy for gastric cancer

In-Hwan Kim

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)

Article Oncology

Gastric Cancer, Version 3.2016

Jaffer A. Ajani et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)

Article Medicine, General & Internal

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Shinichi Sakuramoto et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

David Cunningham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

JS Macdonald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)